维普中文期刊产品整合服务
10篇 您的检索式:作者名="Cheol Kwak"
    题名 作者 年代 出处 被引量
1Dysphagia in patients with isolated pontine infarction显示文摘Little is known about dysphagia after pontine infarction. In this study, we evaluated the incidence of dysphagia after isolated pontine infarction and identified the predictive factors for the occurrence of dysphagia. A total of 146 patients were included in this study. All patients underwent clinical testing for dysphagia within 1 day after admission and at the time of discharge. We compared the incidence of dysphagia between patients with unilateral pontine infarction and those with bilateral pontine infarction. To evaluate the functional status of patients, we investigated their initial modified Rankin Scale(mRS) score and initial National Institutes of Health Stroke Scale(NIHSS) score within 1 day of admission. Of 146 patients, 50(34.2%) had dysphagia initially within 1 day after admission. At the second evaluation at the time of discharge, dysphagia was diagnosed in 24 patients(16.4%). Patients with bilateral pontine infarction were more likely to present with dysphagia. In addition, clinical severity(in terms of mRS and NIHSS scores) was identified as a predictor of dysphagia in patients with cerebral infarction(multiple binary logistic regression analysis, mRS: P = 0.011, NIHSS: P = 0.004). Dysphagia frequently occurs in patients with isolated pontine infarction. Clinicians should pay particular attention to the occurrence of dysphagia, especially in patients with bilateral pontine infarction or high functional disability.Min Cheol Chang Sang Gyu Kwak Min Ho Chun 2018Neural Regeneration Research2018,13,12:11
2Serum prostate-specific antigen value adjusted for non-cancerous prostate tissue volume in patients undergoing radical prostatectomy: a new predictor of biochemical recurrence in localized or locally advanced prostate cancer显示文摘这研究的目的是调查为全部的肿瘤体积(PSA/tumor 体积) 调整的前列腺特定的抗原(PSA ) 价值和浆液 PSA 价值在激进的前列腺切除术以后作为病理学的调查结果和临床的结果的一个预言者为非癌的前列腺织物体积(NCPV )(PSA/NCPV ) 调整了的浆液的意义。407 个病人的临床、病理学的数据(中部的年龄:66.5 年;变化:41.8 鈥 ? 5.7 年) 回顾地被考察。中部的后续时期是 18.1 个月(范围:1.0 鈥 ? 07.8 个月) 。生物化学的复发被定义为可检测的 PSA 层次(比 0.2 ng ml 大 ? 1 ) 并且生物化学的复发的倍被花是第一次 PSA 变得可检测。在 multivariate 模型, PSA/NCPV 是囊外的扩展和积极外科的边缘的一个独立预言者(P < 0.05 ) ,但是 PSA/tumor 体积不。Kaplan 鈥揗e ier 曲线表明 PSA/NCPV 与生物化学的没有复发的幸存相关(P < 0.001;木头等级测试) 但是 PSA/tumor 体积(P=0.275;木头等级测试) 。PSA/NCPV 也是为 multivariate 考克斯上的生物化学的没有复发的幸存的一个重要独立预示的因素比例的危险分析(P=0.004,相对 risk=2.42 ) 。我们的调查结果建议 PSA/NCPV 与囊外的扩展和外科的边缘地位独立地被联系并且可以是在激进的前列腺切除术以后的 PSA 复发的一个独立预示的变量。Ja Hyeon Ku Kyung Chul Moon Sung Yong Cho Cheol Kwak Hyeon Hoe Kim 2011Asian Journal of Andrology2011,13,2:3
3High-dose terazosin therapy (5 mg) in korean patients with lower urinary tract symptoms with or without concomitant hypertension:A prospective,open-label study显示文摘CHEOL KWAK JEONG KI LEE AND JA HYEON KU 2007J Yonsei Med J2007,3148,6:1
4Lymphovascular invasion as a prognostic factor in the upper urinary tract urothelial carcinoma: A systematic review and meta-analysis显示文摘Ja Hyeon Ku Seok-Soo Byun Hyeon Jeong Cheol Kwak Hyeon Hoe Kim Sang Eun Lee 2013European Journal of Cancer2013,,:1
5The Prognostic Significance of the Early Postoperative Neutrophil-to-Lym-phocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy 显示文摘Minyong Kang Chang Wook Jeong Cheol Kwak 2016Ann Surg Oncol2016,23,1:1
6Influence of pain and urinary symptoms on quality of life in young men with chronic prostatitis-like symptoms显示文摘Jahyeon KU Cheol KWAK Seung-june OH 2004International Journal of Urology2004,,11:1
7Metachronous metastatic potential of small renal cell carcinoma: dependence on tumor size显示文摘JA HYEON KU KYUNG CHUL MOON CHEOL KWAK 2009Urology2009,74,:1
8Expressinal cell carcinoma of the bladdet 显示文摘JA HYEON KU CHEOL KWAK HYE SUN LEE 2004J urol2004,171,:1
9Apoptosis induced by oxalate in human renal tubular epithelial HK-2 cells显示文摘Byong-Chang Jeong Cheol Kwak Kyu Seon Cho Bong Sub Kim Sung Kyu Hong Jung-In Kim Chongwook Lee Hyeon Hoe Kim 2005Urological Research2005,,2:1
10Consensus on safety management of novel hormonal therapy for advanced prostate cancer显示文摘Prostate cancer(PCa)is one of the most prevalent malignant tumors in men,accompanied by high incidence and mortality rates.Novel hormonal therapy(NHT)has emerged as the primary treatment for advanced PCa,providing noticeable clinical benefits.However,the diverse range of adverse events(AEs)associated with NHT may influence both treatment efficacy and patients'quality of life.In light of the latest international clinical research evidence and recommendations from domestic and foreign guidelines,this consensus aims to provide a comprehensive overview of the common AEs experienced during NHT for advanced PCa patients.Additionally,it seeks to develop a hierarchical approach to more efficiently manage AEs,presenting valuable insights for clinical medication and adverse reaction management.Sujun Han Shudong Cheng Degang Ding Jianming Guo Zhisong He Baiye Jin Zhigang Ji Tianxin Lin Yuanjie Niu Weijun Qin Benkang Shi Jinkai Shao Xi'nan Sheng Qiang Wei Xin Wang Xinghuan Wang Shujie Xia Wanhai Xu Qing Zou Xiongbing Zu Renu Eapen Chi‐Fai Ng Hirotsugu Uemura Hiroji Uemura Cheol Kwak Jae Young Joung Marniza Saad Edmund Chiong Nianzeng Xing 2023UroPrecision2023,1,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费